首页> 外文期刊>The Journal of Urology >The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors.
【24h】

The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors.

机译:雄激素受体共激活因子p44和蛋白精氨酸甲基转移酶5在发育中的睾丸和睾丸肿瘤中的表达和功能。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: The role of androgen receptor coactivators in testicular development and cancer formation is unclear. p44/Mep50 was identified as an androgen receptor coactivator that functions in a complex with protein arginine methyltransferase 5. We studied the expression of p44 and protein arginine methyltransferase 5 in developing fetal testis and adult testicular tumors, including seminomas and Leydig cell tumors. MATERIALS AND METHODS: A total of 30 human fetal testes from abortuses at a gestational age of 10 to 40 weeks, 33 human seminomas and 11 human Leydig cell tumors were retrieved from the archives of the departments of pathology. Immunohistochemistry was performed with affinity purified p44 and IgG purified protein arginine methyltransferase 5 polyclonal antibodies. RESULTS: Protein arginine methyltransferase 5 and p44 were expressed predominantly as nuclear proteins in fetal Leydig cells and human adult nonneoplastic testes, including germ cells and Leydig cells, while they were expressed in the cytoplasm of germ cells of the fetal testis. Expression was strongest in the fetal testis during the second trimester. Compared to adult nonneoplastic testes, human seminoma and Leydig tumor cells showed a marked decrease in nuclear expression of p44 and protein arginine methyltransferase 5 with a concomitant marked increase in cytoplasmic expression of these proteins. Furthermore, average testicular size was increased by 29% in p44(+/-) heterzygotic mice. CONCLUSIONS: These results suggest distinct functions of the nuclear and the p44/protein arginine methyltransferase 5 complexes in the developing fetal testis and in the oncogenesis of testicular tumors. Further studies are needed to confirm the functional relevance of these findings.
机译:目的:雄激素受体共激活剂在睾丸发育和癌症形成中的作用尚不清楚。 p44 / Mep50被确定为与蛋白精氨酸甲基转移酶5形成复合体的雄激素受体共激活剂。我们研究了p44和蛋白精氨酸甲基转移酶5在发育中的胎儿睾丸和成年睾丸肿瘤(包括精原细胞瘤和Leydig细胞瘤)中的表达。材料与方法:从病理部门的档案中,共收集了30个胎龄为10至40周的人流产睾丸,33个人精原细胞瘤和11个人Leydig细胞瘤。用亲和纯化的p44和IgG纯化的蛋白精氨酸甲基转移酶5多克隆抗体进行免疫组织化学。结果:精氨酸甲基转移酶5和p44主要在胎儿Leydig细胞和人类成年非肿瘤睾丸(包括生殖细胞和Leydig细胞)中以核蛋白形式表达,而在胎儿睾丸生殖细胞的细胞质中表达。在妊娠中期胎儿的睾丸中表达最强。与成人非肿瘤睾丸相比,人类精原细胞瘤和Leydig肿瘤细胞显示p44和精氨酸甲基转移酶5的核表达显着下降,同时这些蛋白的胞质表达也显着增加。此外,p44(+/-)杂合子小鼠的平均睾丸大小增加了29%。结论:这些结果表明,在发育中的胎儿睾丸和睾丸肿瘤的发生中,核和p44 /蛋白精氨酸甲基转移酶5复合物具有独特的功能。需要进一步的研究以确认这些发现的功能相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号